EnteroBiotix LTD, 2026-04-09
An SEC Form D private-offering notice from Glasgow, an undisclosed offering target in Biotech. Filed 2026-04-09. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biopharmaceutical company developing microbiome-based therapeutics for gastrointestinal and other diseases, headquartered in Glasgow, Scotland.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Inso Biosciences Inc., 2026-04-10, $3M, Ithaca, NY
- QMatter, Inc., 2026-04-09, $1.2M, London
- RenovoRx, Inc., 2026-04-09, $10M, Mountain View, CA
- HumanImage Inc, 2026-04-08, $1.5M, Chicago, IL
- Iambic Therapeutics, Inc., 2026-04-08, $50M, San Diego, CA
- Precision Fermentation, Inc., 2026-04-08, $10M, Durham, NC
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.